Literature DB >> 15033421

Hyperthermic pre-conditioning promotes measles virus clearance from brain in a mouse model of persistent infection.

Thomas Carsillo1, Mary Carsillo, Stefan Niewiesk, Daphne Vasconcelos, Michael Oglesbee.   

Abstract

Nervous tissue subjected to hyperthermic pre-conditioning is resistance to numerous insults although in vitro, the same treatment can increase gene expression and cytopathic effect of neurotropic paramyxoviruses, including measles virus (MV). The present work determined whether the in vivo relationship between hyperthermic pre-conditioning and MV infection would be to increase neuropathogenicity or, conversely, to promote clearance. Balb/c mice 36 h of age were exposed to a 41 degrees C hyperthermic treatment for 30 min. Intracranial inoculation of mice with Edmonston MV was performed at 6 h following the heat treatment, a time point exhibiting elevated levels of the major inducible 70-kDa heat shock protein in brain, a hallmark of pre-conditioning. Forty-seven percent of the non-heated animals supported a persistent cytopathic infection at 21-day post infection (PI) based upon the quantitative detection of viral RNA in brain using real time RT-PCR. Cytopathic effect in the infected brains was proportionate to viral RNA burden. In contrast, infected stress conditioned mice lacked significant cytopathic effect and clearance was demonstrated in 95% of the animals. Analysis of shorter post-infection intervals showed that levels of viral RNA in brain were equivalent between stress conditioned and non-conditioned mice at 2 and 7 days PI, with clearance being first evident in both groups at 14 days. The temporal onset and progression of clearance was correlated to splenocyte blastogenic responsiveness to purified MV antigen but not the production of MV-specific antibody. Collectively, these results support the hypothesis that stress conditioning enhances the efficacy of cell-mediated immune responses known to mediate viral clearance from brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033421     DOI: 10.1016/j.brainres.2003.12.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  hsp72, a host determinant of measles virus neurovirulence.

Authors:  Thomas Carsillo; Zachary Traylor; Changsun Choi; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  A single codon in the nucleocapsid protein C terminus contributes to in vitro and in vivo fitness of Edmonston measles virus.

Authors:  Thomas Carsillo; Xinsheng Zhang; Daphne Vasconcelos; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  hsp70-dependent antiviral immunity against cytopathic neuronal infection by vesicular stomatitis virus.

Authors:  Mi Young Kim; Yuanmei Ma; Yu Zhang; Jianrong Li; Yaoling Shu; Michael Oglesbee
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

4.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

5.  Measles virus neurovirulence and host immunity.

Authors:  Michael Oglesbee; Stefan Niewiesk
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

6.  Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.

Authors:  Yuanmei Ma; Yue Duan; Yongwei Wei; Xueya Liang; Stefan Niewiesk; Michael Oglesbee; Jianrong Li
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

7.  Cytokine imbalance after measles virus infection has no correlation with immune suppression.

Authors:  Mary Carsillo; Kay Klapproth; Stefan Niewiesk
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

8.  Major histocompatibility complex haplotype determines hsp70-dependent protection against measles virus neurovirulence.

Authors:  Thomas Carsillo; Mary Carsillo; Zachary Traylor; Päivi Rajala-Schultz; Phillip Popovich; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

9.  hsp70 and a novel axis of type I interferon-dependent antiviral immunity in the measles virus-infected brain.

Authors:  Mi Young Kim; Yaoling Shu; Thomas Carsillo; Jianying Zhang; Lianbo Yu; Cornelia Peterson; Sonia Longhi; Sarah Girod; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 10.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.

Authors:  Dajana Reuter; Jürgen Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 4.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.